This bill mandates the reinstatement and quick disbursement of funding for National Institutes of Health grants terminated or suspended between January 20, 2025, and the date of enactment, along with a one-year extension for the budget period.
Haley Stevens
Representative
MI-11
The Stop RFK’s Bad Science Act mandates the immediate reinstatement of any National Institutes of Health (NIH) grants or awards that were terminated or suspended between January 20, 2025, and the enactment of this law. Reinstated funds must be disbursed to recipients within 30 days of request, and the budget period for these grants is automatically extended by one year. Exceptions to reinstatement only apply if the NIH Director finds evidence of financial mismanagement or research fraud by the recipient.
This bill, nicknamed the “Stop RFK’s Bad Science Act,” aims to hit the reset button on certain federal research funding decisions made by the National Institutes of Health (NIH). Specifically, Section 2 mandates that any NIH grant or award that was terminated or suspended between January 20, 2025, and the date this new law passes must be automatically reinstated. Think of it as a mandatory funding override button for research projects that got caught in recent administrative limbo. The only way the NIH can keep a grant terminated is if the Director finds clear evidence of financial mismanagement or research fraud concerning that specific award.
This is a huge deal for researchers and institutions whose work was suddenly halted. If you’re a scientist whose lab funding was paused—maybe you’re studying a new cancer therapy or tracking a viral outbreak—this means your project is back on the federal dime, effective immediately. The bill ensures that the money for these reinstated grants is “obligated,” meaning the funds are officially set aside again. Furthermore, the current budget period for every reinstated grant gets an automatic one-year extension, giving researchers crucial extra time to catch up on work lost during the suspension period.
The legislation doesn't just reinstate the funding; it puts the NIH on a tight clock to pay up. If your grant is brought back, and you submit a request for payment, the NIH has to disburse that money as quickly as possible, but absolutely no later than 30 calendar days after your request. For busy research institutions, this guaranteed quick turnaround is significant, allowing them to rehire staff, order supplies, and get back to work without months of waiting. However, this tight 30-day deadline could create an administrative bottleneck for the NIH, forcing them to prioritize these payments over other routine administrative tasks.
For the scientific community, this bill is about stability and continuity. Imagine a university research team whose multi-year study was abruptly suspended. This bill ensures that years of data collection and specialized work don't go to waste. By limiting the reasons for non-reinstatement strictly to fraud or financial mismanagement, the law essentially removes other potential political or administrative reasons for pausing grants. While this is great news for the researchers, it does mean that any legitimate, non-fraud-related concerns the NIH might have had when initially pausing the funding are now overridden by the mandate to reinstate, placing the burden of proof squarely on the NIH Director to justify any continued termination.